Timescrolly
Explore
Built for
Features
Plans
Help
Sign in
Get started
EN
Linda-Gail Bekker
South African physician who led the PURPOSE 1 trial of lenacapavir in young women.
Person
1962 –
Identifiers
Wikidata Q30001903
Appears in
1 item
HIV and AIDS
1 item
Twice-yearly lenacapavir is approved for prevention
· leader
18 Jun 2025
Sources
Article
Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women
